NCT02246504 is a NA clinical trial of HIFU treatment in Non-malignant Thyroid Nodule, sponsored by Theraclion.

Who is sponsoring NCT02246504?

NCT02246504 is sponsored by Theraclion.

What drugs are being tested in NCT02246504?

Interventions in NCT02246504: HIFU treatment.

What condition does NCT02246504 study?

NCT02246504 studies Non-malignant Thyroid Nodule.

Is NCT02246504 still recruiting?

NCT02246504 is currently completed. Last updated 17 September 2019.

Last reviewed 2019-09-17 · How we verify

NCT02246504

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Registry - Use of a High Intensity Focused Ultrasound (HIFU) in Patients With Non-malignant Thyroid Nodules.

Completed NA Last updated 17 September 2019

What this trial tests

NA trial testing HIFU treatment in Non-malignant Thyroid Nodule in 20 participants. Completed in 7 March 2017.

Timeline

9 October 2012

Primary endpoint
7 March 2017

7 March 2017

Quick facts

Lead sponsor	Theraclion
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	20
Start date	9 October 2012
Primary completion	7 March 2017
Estimated completion	7 March 2017
Sites	1 location across Bulgaria

Drugs / interventions tested

HIFU treatment

Conditions studied

Non-malignant Thyroid Nodule — all drugs for Non-malignant Thyroid Nodule →

Sponsor

Theraclion — full company profile →

Who can join

18 and older, any sex, with Non-malignant Thyroid Nodule. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to evaluate thyroid nodule's volume, structure and vascularisation changes following HIFU therapy assessed by ultrasonography

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of HIFU treatment

Trials testing the same drug.

NCT07461064 — HIFU vs Observation for LSIL of Cervix: A Randomized Controlled Trial · NA · not yet recruiting
NCT04853914 — Evaluation of the Safety of the Treatment of Benign Prostatic Hyperplasia by High Intensity Focused Ultrasound. · NA · completed
NCT04494568 — Evaluation of High Intensity Focused Ultrasound (HIFU) in the Treatment of Rectal Endometriosis · NA · completed

Other Theraclion trials

Trials by the same sponsor.

NCT05926830 — Extracorporeal Flow Abolition in Relation With Primary Insufficiency of Great Saphenous Veins (GSV) Using High Intensity · NA · completed
NCT04280679 — Treatment of Insufficient Superficial and Perforatring Veins of the Lower Limb Using HIFU · NA · completed
NCT03742401 — Treatment of Breast Fibroadenoma With High Intensity Focused Ultrasound (HIFU) · NA · terminated
NCT03304834 — Treatment of Insufficient Superficial and Perforating Veins of the Lower Limb Using HIFU · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02246504 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Theraclion
Last refreshed: 17 September 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02246504.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing